Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

Srinivasan, G.

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

Issue Date

2023

Our author(s)

Srinivasan, G.

Department

Oncology

Keywords

Oncology

Language

English

Publisher

Lippincott Williams and Wilkins

ISSN

0732-183X
1527-7755

Type

Article

Citation

Suarez, C., Larkin, J. M. G., Patel, P., Valderrama, B. P., Rodriguez-Vida, A., Glen, H., Thistlethwaite, F., Ralph, C., Srinivasan, G., Mendez-Vidal, M. J., Hartmaier, R., Markovets, A., Prendergast, A., Szabados, B., Mousa, K. & Powles, T. 2023. Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). Journal of Clinical Oncology, 41, (14) 2493-2502.